Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.

Fowler, Mary Glenn.Coovadia, Hoosen Mahomed.Herron, Casey M.Maldonado, Yvonne.Chipato, Tsungai.Moodley, Dhayendre.Musoke, Philippa.Aizire, Jim.Manji, Karim.Stranix-Chibanda, Lynda.Fawzi, Wafaie.Chetty, Vani.Msweli, Lindiwe.Kisenge, Rodrick Richard.Brown, Elizabeth R.Mwatha, Anthony.Eshleman, Susan H.Richardson, Paul.Allen, Melissa.George, Kathleen.Andrew, Philip.Zwerski, Sheryl.Mofenson, Lynne Meryl.Jackson, Jay Brooks.2016-10-272016-10-2720132013Fowler, M.G., Coovadia, H., Herron, C.M., Maldonado, Y., Chipato, T., Moodley, D., Musoke, P., Aizire, J., Manji, K., Stranix-Chibanda, L., Fawzi, W., Chetty V., Msweli L., Kisenge R., Brown E., Mwatha A., Eshleman S. H., Richardson P., Allen M., George K., Andrew P., Zwerski S., Mofenson L. M., and Jackson J. B.; HPTN 046 Protocol Team. 2013. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. Journal of acquired immune deficiency syndromes 65(3), 366-374.http://dx.doi.org/10.1097/QAI.0000000000000052http://hdl.handle.net/10413/13547CAPRISA, 2013.Abstract available in PDF file.enNevirapine.Infant HIV prophylaxis.PMTCT.Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.Peer reviewed journal article